The efficacy and safety of tigecycline for the treatment of bloodstream infections: a systematic review and meta-analysis
Abstract Patients with bloodstream infections (BSI) are associated with high mortality rates. Due to tigecycline has shown excellent in vitro activity against most pathogens, tigecycline is selected as one of the candidate drugs for the treatment of multidrug-resistant organisms infections. The purp...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-04-01
|
Series: | Annals of Clinical Microbiology and Antimicrobials |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12941-017-0199-8 |